The COVID-19 vaccine provided more than a defense against a deadly virus; it introduced mRNA’s transformative journey in modern healthcare.
(3 min read)
The Power of mRNA: Vaccines, Treatments, and the Road Ahead
read more
Stay Updated! Subscribe to The Primer
Share
New Gene Therapy Drug Explained
In March 2023, Novartis’ (Basel, Switzerland), shared its latest data concerning Zolgensma. The findings reveal sustained durability up to 7.5 years post-dosing, with a 100% achievement of all assessed milestones in children treated before the onset of spinal muscular...
Biotech Primer is your go-to source for interactive training across the biotechnology, pharmaceutical, molecular diagnostics, and medical device sectors. Explore a range of in-depth biotech courses designed to deepen your understanding of key principles and applications in the field.